4//SEC Filing
Foster-Cheek Kaye I 4
Accession 0001439222-24-000091
CIK 0001439222other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 5:32 PM ET
Size
9.2 KB
Accession
0001439222-24-000091
Insider Transaction Report
Form 4
Foster-Cheek Kaye I
Director
Transactions
- Gift
Common stock
2024-06-13−3,564→ 5,348 total - Exercise/Conversion
Restricted stock units
2024-06-13−3,388→ 0 total→ Common stock (3,388 underlying) - Exercise/Conversion
Common stock
2024-06-13+3,388→ 8,912 total
Holdings
- 2,200(indirect: By Trust)
Common stock
Footnotes (3)
- [F1]This disposition reflects a gift of 3,564 shares to a not-for-profit organization.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F3]The restricted stock units were granted on June 13, 2023. The shares underlying the stock units vest in full on June 13, 2024. Vested shares will be delivered to the reporting person within three business days after such shares become vested.
Documents
Issuer
AGIOS PHARMACEUTICALS, INC.
CIK 0001439222
Entity typeother
Related Parties
1- filerCIK 0001312622
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 5:32 PM ET
- Size
- 9.2 KB